Journal
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Volume 90, Issue 3, Pages 262-283Publisher
WILEY
DOI: 10.1111/j.1365-2613.2009.00646.x
Keywords
angiogenic therapy; coronary angiogenesis; coronary vasculogenesis; epicardium; neovascularization
Categories
Funding
- British Heart Foundation
- Medical Research Council
- British Heart Foundation [FS/08/004/23625] Funding Source: researchfish
- Medical Research Council [G0200073] Funding Source: researchfish
- MRC [G0200073] Funding Source: UKRI
Ask authors/readers for more resources
Formation of the coronary arteries consists of a precisely orchestrated series of morphogenetic and molecular events which can be divided into three distinct processes: vasculogenesis, angiogenesis and arteriogenesis ( Risau 1997; Carmeliet 2000). Even subtle perturbations in this process may lead to congenital coronary artery anomalies, as occur in 0.2-1.2% of the general population (von Kodolitsch et al. 2004). Contrary to the previously held dogma, the process of vasculogenesis is not limited to prenatal development. Both vasculogenesis and angiogenesis are now known to actively occur within the adult heart. When the need for regeneration arises, for example in the setting of coronary artery disease, a reactivation of embryonic processes ensues, redeploying many of the same molecular regulators. Thus, an understanding of the mechanisms of embryonic coronary vasculogenesis and angiogenesis may prove invaluable in developing novel strategies for cardiovascular regeneration and therapeutic coronary angiogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available